328 related articles for article (PubMed ID: 29998397)
1. Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.
Hirsch TZ; Martin-Lannerée S; Reine F; Hernandez-Rapp J; Herzog L; Dron M; Privat N; Passet B; Halliez S; Villa-Diaz A; Lacroux C; Klein V; Haïk S; Andréoletti O; Torres JM; Vilotte JL; Béringue V; Mouillet-Richard S
Mol Neurobiol; 2019 Mar; 56(3):2159-2173. PubMed ID: 29998397
[TBL] [Abstract][Full Text] [Related]
2. The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells.
Martin-Lannerée S; Halliez S; Hirsch TZ; Hernandez-Rapp J; Passet B; Tomkiewicz C; Villa-Diaz A; Torres JM; Launay JM; Béringue V; Vilotte JL; Mouillet-Richard S
Stem Cells; 2017 Mar; 35(3):754-765. PubMed ID: 27641601
[TBL] [Abstract][Full Text] [Related]
3.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
4. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
5. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
6. Understanding the neurospecificity of Prion protein signaling.
Schneider B; Pietri M; Pradines E; Loubet D; Launay JM; Kellermann O; Mouillet-Richard S
Front Biosci (Landmark Ed); 2011 Jan; 16(1):169-86. PubMed ID: 21196165
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.
Hara H; Sakaguchi S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872280
[TBL] [Abstract][Full Text] [Related]
8. The first non-prion pathogen identified: neurotropic influenza virus.
Sakaguchi S; Hara H
Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
[TBL] [Abstract][Full Text] [Related]
9. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
Macedo B; Cordeiro Y
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
[TBL] [Abstract][Full Text] [Related]
10. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
11. The cellular and pathologic prion protein.
Gill AC; Castle AR
Handb Clin Neurol; 2018; 153():21-44. PubMed ID: 29887138
[TBL] [Abstract][Full Text] [Related]
12. RhoA/ROCK Regulates Prion Pathogenesis by Controlling Connexin 43 Activity.
Kim HJ; Kim MJ; Mostafa MN; Park JH; Choi HS; Kim YS; Choi EK
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070020
[TBL] [Abstract][Full Text] [Related]
13. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal Quality Control in Prion Diseases.
Majumder P; Chakrabarti O
Mol Neurobiol; 2018 Mar; 55(3):2631-2644. PubMed ID: 28421536
[TBL] [Abstract][Full Text] [Related]
15. Prion protein self-interaction in prion disease therapy approaches.
Rigter A; Priem J; Langeveld JP; Bossers A
Vet Q; 2011 Sep; 31(3):115-28. PubMed ID: 22029882
[TBL] [Abstract][Full Text] [Related]
16. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives.
Hernaiz A; Toivonen JM; Bolea R; Martín-Burriel I
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293477
[TBL] [Abstract][Full Text] [Related]
18. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
19. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
20. PrP knock-out and PrP transgenic mice in prion research.
Weissmann C; Flechsig E
Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
